RightAnswer Knowledge Solutions provides access to hundreds of data sources. Our premier and proprietary sources include fully-researched documents from well-established experts in the chemical and HazMat fields.
A search in our system for this chemical would return results – all in one place -- in the following categories from the listed data sources.
- Chemical Identification
- Environmental Hazards
- First Aid/Medical Treatment
- Handling/Storage/Shipping/Waste Management
- Personal Protection
- Physical Hazards/Corrective Response Actions
- Physical/Chemical Properties
- Report Abstracts and Studies
- Reproductive Risk
- Toxicology/Health Hazards/Exposure
|Example of Acute Exposure data from MEDITEXT.|
RightAnswer Proprietary Data Sources:
Other Government Links Searched via RegsKnowledge:
State Environmental Regulations
Example Content from MEDITEXT for 52485-79-7:
Please note: this is an extract of information from a larger document. Full document and details are available by subscription.
ACUTE EXPOSURE INFORMATION
- USES: Schedule III prescription medication used for opioid addiction maintenance therapy.
- PHARMACOLOGY: Partial agonist at the mu-opioid receptor, antagonist at the kappa opioid receptor.
- TOXICOLOGY: The toxicity is an extension of the pharmacology. Effects include CNS depression, respiratory depression, constipation, and euphoria. Hypotension can occur from mast cell G protein activation and subsequent degranulation of histamine-containing vesicles.
- EPIDEMIOLOGY: Buprenorphine exposures are common. In adults, severe toxicity may occur from crushing and injecting tablets, but is not common after ingesting buprenorphine alone. Children are at risk for toxicity following ingestion of less than a single tablet. While most deaths are due to overdose, deaths following inadvertent ingestion have occurred.
- WITH THERAPEUTIC USE
- Sedation, headache, nausea, vomiting, abdominal pain, constipation, and withdrawal syndrome. At high doses, buprenorphine's agonist effects plateau ("ceiling effect"), limiting the maximum analgesic and respiratory depressant effects. Due to this "ceiling effect," patients who are chronic users/abusers of opioids can experience withdrawal after ingestion of buprenorphine.
- WITH POISONING/EXPOSURE
- MILD TO MODERATE POISONING: Miosis, sedation, and relative bradycardia. Hepatitis is reported rarely.
- SEVERE POISONING: CNS depression, coma, respiratory depression, and hypotension. Children, in particular, may develop profound, recurrent, or delayed CNS and respiratory depression. In adults, severe effects are generally only seen after crushing and injecting tablets, or after very large ingestions. Acute renal failure is reported rarely.
© 2011-2020 RightAnswer.com, Inc. and/or its licensors. All rights reserved. No claim to original U.S. Govt. works.